124 related articles for article (PubMed ID: 25810575)
1. Role of CTCF poly(ADP-Ribosyl)ation in the regulation of apoptosis in breast cancer cells.
Venkatraman B; Klenova E
Indian J Med Paediatr Oncol; 2015; 36(1):49-54. PubMed ID: 25810575
[TBL] [Abstract][Full Text] [Related]
2. Decreased poly(ADP-ribosyl)ation of CTCF, a transcription factor, is associated with breast cancer phenotype and cell proliferation.
Docquier F; Kita GX; Farrar D; Jat P; O'Hare M; Chernukhin I; Gretton S; Mandal A; Alldridge L; Klenova E
Clin Cancer Res; 2009 Sep; 15(18):5762-71. PubMed ID: 19737964
[TBL] [Abstract][Full Text] [Related]
3. Nuclear PTEN interferes with binding of Ku70 at double-strand breaks through post-translational poly(ADP-ribosyl)ation.
Guan J; Zhao Q; Mao W
Biochim Biophys Acta; 2016 Dec; 1863(12):3106-3115. PubMed ID: 27741411
[TBL] [Abstract][Full Text] [Related]
4. Poly(ADP-ribosyl)ation associated changes in CTCF-chromatin binding and gene expression in breast cells.
Pavlaki I; Docquier F; Chernukhin I; Kita G; Gretton S; Clarkson CT; Teif VB; Klenova E
Biochim Biophys Acta Gene Regul Mech; 2018 Aug; 1861(8):718-730. PubMed ID: 29981477
[TBL] [Abstract][Full Text] [Related]
5. Heightened expression of CTCF in breast cancer cells is associated with resistance to apoptosis.
Docquier F; Farrar D; D'Arcy V; Chernukhin I; Robinson AF; Loukinov D; Vatolin S; Pack S; Mackay A; Harris RA; Dorricott H; O'Hare MJ; Lobanenkov V; Klenova E
Cancer Res; 2005 Jun; 65(12):5112-22. PubMed ID: 15958555
[TBL] [Abstract][Full Text] [Related]
6. Poly(ADP-ribosyl)ation of p53 in vitro and in vivo modulates binding to its DNA consensus sequence.
Simbulan-Rosenthal CM; Rosenthal DS; Luo RB; Samara R; Jung M; Dritschilo A; Spoonde A; Smulson ME
Neoplasia; 2001; 3(3):179-88. PubMed ID: 11494111
[TBL] [Abstract][Full Text] [Related]
7. Oocyte numbers in the mouse increase after treatment with 5-aminoisoquinolinone: a potent inhibitor of poly(ADP-ribosyl)ation.
Qian H; Xu J; Lalioti MD; Gulle K; Sakkas D
Biol Reprod; 2010 May; 82(5):1000-7. PubMed ID: 20107208
[TBL] [Abstract][Full Text] [Related]
8. CTCF participates in DNA damage response via poly(ADP-ribosyl)ation.
Han D; Chen Q; Shi J; Zhang F; Yu X
Sci Rep; 2017 Mar; 7():43530. PubMed ID: 28262757
[TBL] [Abstract][Full Text] [Related]
9. Poly(ADP-ribosyl)ation in carcinogenesis.
Masutani M; Fujimori H
Mol Aspects Med; 2013 Dec; 34(6):1202-16. PubMed ID: 23714734
[TBL] [Abstract][Full Text] [Related]
10. Poly(ADP-ribosyl)ation reactions in the regulation of nuclear functions.
D'Amours D; Desnoyers S; D'Silva I; Poirier GG
Biochem J; 1999 Sep; 342 ( Pt 2)(Pt 2):249-68. PubMed ID: 10455009
[TBL] [Abstract][Full Text] [Related]
11. Up-regulation of two distinct p53-DNA binding functions by covalent poly(ADP-ribosyl)ation: transactivating and single strand break sensing.
Alvarez-Gonzalez R; Mendoza-Alvarez H; Frey M; Zentgraf H
Cancer Invest; 2013 Nov; 31(9):563-70. PubMed ID: 24164297
[TBL] [Abstract][Full Text] [Related]
12. Poly(ADP-ribosyl)ation: a posttranslational protein modification linked with genome protection and mammalian longevity.
Bürkle A
Biogerontology; 2000; 1(1):41-6. PubMed ID: 11707919
[TBL] [Abstract][Full Text] [Related]
13. Poly(ADP-ribosyl)ation: its role in inducible DNA amplification, and its correlation with the longevity of mammalian species.
Bürkle A; Grube K; Küpper JH
Exp Clin Immunogenet; 1992; 9(4):230-40. PubMed ID: 1307244
[TBL] [Abstract][Full Text] [Related]
14. Inhibition of Crm1-p53 interaction and nuclear export of p53 by poly(ADP-ribosyl)ation.
Kanai M; Hanashiro K; Kim SH; Hanai S; Boulares AH; Miwa M; Fukasawa K
Nat Cell Biol; 2007 Oct; 9(10):1175-83. PubMed ID: 17891139
[TBL] [Abstract][Full Text] [Related]
15. New polymorphisms in the human poly(ADP-ribose) polymerase-1 coding sequence: lack of association with longevity or with increased cellular poly(ADP-ribosyl)ation capacity.
Cottet F; Blanché H; Verasdonck P; Le Gall I; Schächter F; Bürkle A; Muiras ML
J Mol Med (Berl); 2000; 78(8):431-40. PubMed ID: 11097112
[TBL] [Abstract][Full Text] [Related]
16. Glucocorticoid-induced cell death and poly[adenosine diphosphate(ADP)-ribosyl]ation: increased toxicity of dexamethasone on mouse S49.1 lymphoma cells with the poly(ADP-ribosyl)ation inhibitor benzamide.
Wielckens K; Delfs T
Endocrinology; 1986 Nov; 119(5):2383-92. PubMed ID: 2429833
[TBL] [Abstract][Full Text] [Related]
17. Effect of zinc on cellular poly(ADP-ribosyl)ation capacity.
Kunzmann A; Dedoussis G; Jajte J; Malavolta M; Mocchegiani E; Bürkle A
Exp Gerontol; 2008 May; 43(5):409-14. PubMed ID: 18022337
[TBL] [Abstract][Full Text] [Related]
18. Enhanced poly(ADP-ribosyl)ation after focal ischemia in rat brain.
Tokime T; Nozaki K; Sugino T; Kikuchi H; Hashimoto N; Ueda K
J Cereb Blood Flow Metab; 1998 Sep; 18(9):991-7. PubMed ID: 9740102
[TBL] [Abstract][Full Text] [Related]
19. Induction of poly(ADP-ribosyl)ation in the kidney after in vivo application of renal carcinogens.
McLaren J; Boulikas T; Vamvakas S
Toxicology; 1994 Mar; 88(1-3):101-12. PubMed ID: 8160192
[TBL] [Abstract][Full Text] [Related]
20. Modulation of transcription by PARP-1: consequences in carcinogenesis and inflammation.
Aguilar-Quesada R; Muñoz-Gámez JA; Martín-Oliva D; Peralta-Leal A; Quiles-Pérez R; Rodríguez-Vargas JM; Ruiz de Almodóvar M; Conde C; Ruiz-Extremera A; Oliver FJ
Curr Med Chem; 2007; 14(11):1179-87. PubMed ID: 17504138
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
